A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 10, 2007, Pages 4036-4041

  Amos Landgraf, James M ^b   Kwong, Lawrence N ^b   Kendziorski, Christina M ^a   Reichelderfer, Mark ^a   Torrealba, Jose ^a   Weichert, Jamey ^a   Haag, Jill D ^b   Chen, Kai Shun ^b   Waller, Jordy L ^b   Gould, Michael N ^b   Dove, William F ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Chromosome biology; Endoscopy; Genomic instability; Min mouse; Virtual colonoscopy

Indexed keywords

MUTAGENIC AGENT; APC PROTEIN; CELECOXIB; NONSTEROID ANTIINFLAMMATORY AGENT; PYRAZOLE DERIVATIVE; SULFONAMIDE;

ADENOMATOUS POLYP; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APC GENE; ARTICLE; CANCER LOCALIZATION; CANCER MODEL; CANCER PATIENT; CHROMOSOME LOSS; COLON; COLON CANCER; CONTROLLED STUDY; ENDOSCOPY; FAMILIAL CANCER; FEMALE; GENE; GENE TARGETING; GENOTYPE PHENOTYPE CORRELATION; LONGITUDINAL STUDY; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE STRAIN; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SMALL INTESTINE; WILD TYPE; ANIMAL; COLON TUMOR; DISEASE MODEL; FISCHER 344 RAT; GENETICS; HETEROZYGOSITY LOSS; HOMOZYGOTE; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

MURINAE; PYRONIA TITHONUS; RATTUS;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; GENES, APC; HOMOZYGOTE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICE; PYRAZOLES; RATS; RATS, INBRED F344; SULFONAMIDES;

EID: 34247231997     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0611690104     Document Type: Article

References (32)

1. American Cancer Society (2006) Cancer Facts & Figures 2006 (Am Cancer Soc, Atlanta).
2. Kinzler KW, Vogelstein B (1998) in The Genetic Basis of Human Cancer, eds Vogelstein B, Kinzler KW (McGraw-Hill, New York), pp 241-242.
3. Moser AR, Pitot HC, Dove WF (1990) Science 247:322-324.
4. Aoki K, Tamai Y, Horiike S, Oshima M, Taketo MM (2003) Nat Genet 35:323-330.
5. Sodir NM, Chen X, Park R, Nickel AE, Conti PS, Moats R, Bading JR, Shibata D, Laird PW (2006) Cancer Res 66:8430-8438.
6. Dove WF, Clipson L, Gould KA, Luongo C, Marshall DJ, Moser AR, Newton MA, Jacoby RF (1997) Cancer Res 57:812-814.
7. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) Nature 445:106-110.
8. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R (2007) Nature 445:111-115
9. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, et al. (2006) Science 314:268-274.
10. Zan Y, Haag JD, Chen KS, Shepel LA, Wigington D, Wang YR, Hu R, Lopez-Guajardo CC, Brose HL, Porter KI, et al. (2003) Nat Biotechnol 21:645-651.
11. Chen KS, Gould MN (2004) Biotechniques 37:383-388.
12. Smits BM, Mudde JB, van de BJ, Verheul M, Olivier J, Homberg J, Guryev V, Cools AR, Ellenbroek BA, Plasterk RH, et al. (2006)Pharmacogenet Genomics 16:159-169.
13. Smits BM, Guryev V, Zeegers D, Wedekind D, Hedrich HJ, Cuppen E (2005) BMC Genomics 6:170.
14. Nordlinger B, Panis Y, Puts JP, Herve JP, Delelo R, Ballet F (1991) Dis Colon Rectum 34:658-663.
15. Shoemaker AR, Moser AR, Midgley CA, Clipson L, Newton MA, Dove WF (1998) Proc Natl Acad Sci USA 95:10826-10831.
16. Haigis KM, Dove WF (2003) Nat Genet 33:33-39.
17. Jacoby RF, Marshall DJ, Newton MA, Novakovic K, Tutsch K, Cole CE, Lubet RA, Kelloff GJ, Verma A, Moser AR, et al. (1996) Cancer Res 56:710-714.
18. Beazer-Barclay Y, Levy DB, Moser AR, Dove WF, Hamilton SR, Vogelstein B, Kinzler KW (1996) Carcinogenesis 17:1757-1760.
19. Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA (2000) Cancer Res 60:5040-5044.
20. Corpet DE, Pierre F (2003) Cancer Epidemiol Biomarkers Prev 12:391-400.
21. Bulow S, Bjork J, Christensen IJ, Fausa O, Jarvinen H, Moesgaard F, Vasen HF (2004) Gut 53:381-386.
22. Schulmann K, Hollerbach S, Kraus K, Willert J, Vogel T, Moslein G, Pox C, Reiser M, Reinacher-Schick A, Schmiegel W (2005) Am J Gastroenterol 100:27-37.
23. Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, Wong RK, Nugent PA, Mysliwiec PA, Schindler WR (2003) N Engl J Med 349:2191-2200.
24. Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S, Scott G, Steffen D, Worley KC, Burch PE, et al. (2004) Nature 428:493-521.
25. Shisa H, Lu L, Katoh H, Kawarai A, Tanuma J, Matsushima Y, Hiai H (1997) Mamm Genome 8:324-327.
26. Jackson-Thompson J, Ahmed F, German RR, Lai SM, Friedman C (2006) Cancer 107:1103-1111.
27. Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J, Nowacki MP, Butruk E (2006) N Engl J Med 355:1863-1872.
28. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC et al. (2002) J Am Med Assoc 288:321-333.
29. Moser AR, Mattes EM, Dove WF, Lindstrom MJ, Haag JD, Gould MN (1993) Proc Natl Acad Sci USA 90:8977-8981.
30. Haigis KM, Caya JG, Reichelderfer M, Dove WF (2002) Proc Natl Acad Sci USA 99:8927-8931.
31. Corpet DE, Pierre F (2005) Eur J Cancer 41:1911-1922.
32. Kohno H, Suzuki R, Yasui Y, Hosokawa M, Miyashita K, Tanaka T (2004) Cancer Sci 95:481-486.